Royal Bank of Canada Increases Diversified Healthcare Trust (NASDAQ:DHC) Price Target to $3.00

Diversified Healthcare Trust (NASDAQ:DHC) had its price target boosted by research analysts at Royal Bank of Canada from $2.00 to $3.00 in a note issued to investors on Monday, Benzinga reports. The firm presently has an “underperform” rating on the real estate investment trust’s stock. Royal Bank of Canada’s price target points to a potential downside of 15.97% from the company’s previous close.

DHC has been the subject of several other research reports. JMP Securities reiterated a “market perform” rating on shares of Diversified Healthcare Trust in a research note on Wednesday, August 21st. B. Riley lifted their price objective on shares of Diversified Healthcare Trust from $5.00 to $6.00 and gave the company a “buy” rating in a research note on Monday, August 5th. Finally, StockNews.com lowered shares of Diversified Healthcare Trust from a “hold” rating to a “sell” rating in a research note on Saturday, August 31st.

Diversified Healthcare Trust Stock Up 1.7 %

Diversified Healthcare Trust stock opened at $3.57 on Monday. The company has a debt-to-equity ratio of 1.36, a quick ratio of 11.63 and a current ratio of 11.63. Diversified Healthcare Trust has a 52-week low of $1.68 and a 52-week high of $4.24. The firm has a 50 day moving average price of $3.51 and a two-hundred day moving average price of $3.01. The firm has a market cap of $858.83 million, a price-to-earnings ratio of -2.41 and a beta of 2.22.

Diversified Healthcare Trust (NASDAQ:DHC) last released its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported ($0.41) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.44). The company had revenue of $371.39 million during the quarter, compared to the consensus estimate of $372.11 million. Diversified Healthcare Trust had a negative net margin of 24.14% and a negative return on equity of 15.36%. During the same quarter in the prior year, the firm earned $0.05 EPS. Equities analysts predict that Diversified Healthcare Trust will post 0.2 EPS for the current year.

Institutional Trading of Diversified Healthcare Trust

A number of hedge funds and other institutional investors have recently bought and sold shares of DHC. Allspring Global Investments Holdings LLC increased its stake in Diversified Healthcare Trust by 99.5% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 15,300 shares of the real estate investment trust’s stock valued at $38,000 after purchasing an additional 7,629 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new position in Diversified Healthcare Trust during the 1st quarter worth $187,000. Atomi Financial Group Inc. purchased a new position in Diversified Healthcare Trust during the 1st quarter worth $46,000. CANADA LIFE ASSURANCE Co boosted its holdings in Diversified Healthcare Trust by 2.1% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 245,882 shares of the real estate investment trust’s stock worth $602,000 after acquiring an additional 4,974 shares during the last quarter. Finally, Black Maple Capital Management LP purchased a new position in Diversified Healthcare Trust during the 1st quarter worth $246,000. Institutional investors own 75.98% of the company’s stock.

Diversified Healthcare Trust Company Profile

DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location.